Inventiva's share price soared by over 4% after the AGM on June 20 authorized a share buyback program for up to 10% of the capital of the biopharmaceutical company specializing in NASH (non-alcoholic steatohepatitis).

The maximum number of treasury shares that may be acquired, based on the share capital at May 31, is 5,247,718, but taking into account the 115,681 shares held in treasury, only 5,132,037 shares may be purchased.

Copyright (c) 2024 CercleFinance.com. All rights reserved.